Results 161 to 170 of about 378,748 (310)

When "right" goes wrong: poor accuracy of calculated right adrenal vein aldosterone levels in subtyping primary aldosteronism. [PDF]

CVIR Endovasc
Datta S, Wang R, Bhalla V, Bahrainwala JZ, Seav S, Picel AC, Wang D, Hung ML.   +7 more
europepmc   +1 more source

Pharmacological management of adrenal disease

, 2019
Adrenal insufficiency is a life-threatening disorder that can be caused by primary adrenal failure or secondary adrenal disease due to damage of Hypothalamic Patuitary Axis. The treatment of choice is hydrocortisone.
Shetah, Lee
core  

Prenatal betamethasone–postnatal N‐methyl‐D‐aspartic acid model of spasms: Update on mechanisms and treatments

Epilepsia Open, EarlyView.
Abstract Infantile epilepsy spasms syndrome (IESS), formerly known as infantile spasms or West Syndrome, is a severe epilepsy syndrome affecting about 3 in 10,000 newborns in the United States. Characterized by clusters of epileptic spasms, interictal hypsarrhythmia, and developmental delays, IESS has diverse causes, including structural‐metabolic ...
Kayla Vieira, Antonia Schonwald, Chian‐Ru Chern, Kamya Shah, Jana Velíšková, Libor Velíšek   +5 more
wiley   +1 more source

Tumor-specific <i>KCNJ5</i> mutation in an aldosterone-producing adenoma not detected in adrenal venous plasma cell-free DNA. [PDF]

JCEM Case Rep
Aono D, Kato T, Kometani M, Yoneda T, Hosomichi K, Karashima S.   +5 more
europepmc   +1 more source

Ketogenic diet for infantile epileptic spasms

Epilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury, Anamika Choudhary, Andy Cheuk‐Him Ng, Cezar Gavrilovici   +3 more
wiley   +1 more source

Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing's syndrome. [PDF]

Ther Adv Endocrinol Metab
Qin Y, Hong S.
europepmc   +1 more source

The gut microbiome and drug‐resistant epilepsy: Microbiome–antiseizure medication interactions and implications for pharmacoresistance

Epilepsia Open, EarlyView.
Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar, Majd A. AbuAlrob, Musab Ali, Simona Lattanzi, Boulenouar Mesraoua   +4 more
wiley   +1 more source

Ectopic adrenal cortical adenoma arising within the kidney in the setting of adrenal-renal fusion: Two cases mimicking renal cell carcinoma and the role of biopsy and ablation. [PDF]

Radiol Case Rep
Jain R, Dallas A, Xu H, Shwaiki O, Salloum E, Tong WL.   +5 more
europepmc   +1 more source

Impact of vigabatrin on risk of relapse of infantile spasms

Epilepsia Open, EarlyView.
Abstract Objective Vigabatrin is an effective treatment for infantile epileptic spasms syndrome (IESS), but relapse remains a clinical challenge. The ideal dose and duration of treatment after response are unknown. We set out to identify treatment‐related predictors of IESS relapse after initial vigabatrin response. Methods We conducted a retrospective
Yaretson I. Carmenate, Hayoung E. Ahn, Haley R. Peters, Hiroki Nariai, Rajsekar R. Rajaraman, Shaun A. Hussain   +5 more
wiley   +1 more source

Extramedullary hematopoiesis presenting as a large adrenal mass mimicking adrenocortical carcinoma in a primary myelofibrosis patient: A case report. [PDF]

Urol Case Rep
Rakhshan A, Besharati S, Moradi Shahrbaback M, Yousefi M.   +3 more
europepmc   +1 more source